Treatment with IL‐12‐LNP significantly reduced liver tumor burden in HCC transgenic mice. IL‐12‐LNP elicited marked infiltration of activated CD44+ CD3+ CD4+ T helper cells into the tumor and increased the production of Interferon γ (IFNγ). The gene discussed is CD4; the disease is hepatocellular carcinoma.